Outcome of Committee Meeting
Natco Pharma Ltd has informed BSE that the Committee of Directors at its meeting held on September 15, 2015 has decided to close the Issue with immediate effect.15-09-2015
15-09-2015
IPA, Natco withdraws pre-grant opposition against a patent application of Gilead for drug Sovaldi
We wanted to tell the big pharma that IPA is not unreasonable and we are not blindly following an idea, said IPA13-09-2015
Natco Pharma raises Rs350 crore through QIP
The firm plans to use the proceeds raised from QIP for capital expenditure and long-term working capital requirements11-09-2015
Outcome of Board Meeting
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 10, 2015, inter alia, has considered the following items of business:1. Approved the Preliminary Placement Document (PPD) for issue of equity shares under the Qualified Institutions Placement (QIP) for which issue is opened....10-09-2015
AGM on Sept 26, 2015
Natco Pharma Ltd has informed BSE that the 32nd Annual General Meeting (AGM) of the Company will be held on September 26, 2015.04-09-2015
Natco Pharma on capex spree, to invest Rs 300 crore
Natco Pharma Ltd has lined up a series of investments for new plants and augmenting existing capacities. "We are going for an aggressive capex in Andhra Pradesh, Telangana and Tamil...31-08-2015
Fixes Book Closure for AGM (Cut-off date for e-voting)
Natco Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2015 to September 26, 2015 (both days inclusive) for the purpose of 32nd Annual General Meeting (AGM) of the Company to be held on September 26, 2015.The Cut-off Date for ascertaining members of the Company who are eligible to cast their vote electronically is September 18, 2015.26-08-2015
NATCO receives FIPB approval for Qualified Institutional Placement for up to Rs.450 crores and Foreign Investment limit increase to 31.5%
Natco Pharma Ltd has informed BSE regarding a Press Release dated August 13, 2015 titled "NATCO receives FIPB approval for Qualified Institutional Placement for up to Rs.450 crores and Foreign Investment limit increase to 31.5%".13-08-2015
Natco profit dips 15.6% to `28.2 crore
Sales rose 14.2% to `227.5 crore from `199.2 crore12-08-2015
Outcome of Board Meeting
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2015, inter alia, has considered the following items of business :1. Termination of earlier Natco Employee Stock Option Plan, 2010 (NATSOP2010).2. Board had discussed the item of raising of funds for one of the subsidiaries Timecap Overseas Ltd., Mauritius and authorised Vice Chairman & CEO to explore various options for the same....12-08-2015